NCI Funds 4-Year Projects at 12 Tobacco Research Centers

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 12
Volume 9
Issue 12

BETHESDA, Md-The National Cancer Institute (NCI) has launched its new antismoking initiative, Research in State and Community Tobacco Control Interventions, by awarding 12 grants totaling $13 million. The money will support the first year of 4-year research projects on local, state, and multistate tobacco prevention and control programs.

BETHESDA, Md—The National Cancer Institute (NCI) has launched its new antismoking initiative, Research in State and Community Tobacco Control Interventions, by awarding 12 grants totaling $13 million. The money will support the first year of 4-year research projects on local, state, and multistate tobacco prevention and control programs.

The first awards in the NCI program went to researchers at the University of Alabama at Birmingham; AMC Cancer Research Center, Denver; University of Illinois at Chicago; Battelle Centers for Public Health Research and Evaluation, Baltimore; and University of Massachusetts campuses at Amherst and Boston.

Grants also went to the University of Massachusetts Medical School; University of Minnesota School of Public Health; Roswell Park Cancer Institute; Oregon Research Institute, Eugene; Kaiser Permanente Center for Health Research, Portland, Oregon; and University of Texas Health Science Center at Houston.

Recent Videos
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content